SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 4.226
AS - Asia 3.286
EU - Europa 1.434
SA - Sud America 480
AF - Africa 284
Continente sconosciuto - Info sul continente non disponibili 201
OC - Oceania 31
AN - Antartide 1
Totale 9.943
Nazione #
US - Stati Uniti d'America 4.004
SG - Singapore 1.027
IT - Italia 588
CN - Cina 551
VN - Vietnam 292
BR - Brasile 273
BD - Bangladesh 239
HK - Hong Kong 227
DE - Germania 160
GB - Regno Unito 159
ID - Indonesia 159
IN - India 157
EG - Egitto 156
JP - Giappone 127
FR - Francia 108
CA - Canada 97
IQ - Iraq 96
MX - Messico 90
FI - Finlandia 82
TR - Turchia 70
NL - Olanda 55
EC - Ecuador 54
RU - Federazione Russa 52
PK - Pakistan 47
PH - Filippine 44
IR - Iran 43
ZA - Sudafrica 42
AR - Argentina 40
PL - Polonia 38
SA - Arabia Saudita 38
MY - Malesia 30
AU - Australia 29
CO - Colombia 29
ES - Italia 28
TW - Taiwan 28
KR - Corea 27
UA - Ucraina 27
PE - Perù 26
AT - Austria 22
BO - Bolivia 19
KE - Kenya 18
SE - Svezia 18
CL - Cile 15
VE - Venezuela 15
CH - Svizzera 13
CZ - Repubblica Ceca 12
NG - Nigeria 12
BE - Belgio 11
DZ - Algeria 11
MA - Marocco 11
JO - Giordania 10
HU - Ungheria 9
JM - Giamaica 9
RO - Romania 8
IE - Irlanda 7
IL - Israele 7
PS - Palestinian Territory 7
TN - Tunisia 7
HN - Honduras 6
KZ - Kazakistan 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
LB - Libano 5
LT - Lituania 5
LY - Libia 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
UZ - Uzbekistan 5
AL - Albania 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
LV - Lettonia 4
MG - Madagascar 4
PA - Panama 4
AZ - Azerbaigian 3
LK - Sri Lanka 3
MM - Myanmar 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
VC - Saint Vincent e Grenadine 3
BF - Burkina Faso 2
BG - Bulgaria 2
CY - Cipro 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LS - Lesotho 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AQ - Antartide 1
BH - Bahrain 1
Totale 9.723
Città #
Singapore 620
Ashburn 619
San Jose 450
Dallas 371
Santa Clara 253
Hong Kong 204
Beijing 193
Council Bluffs 168
Los Angeles 136
Fairfield 108
Chandler 103
Ho Chi Minh City 102
New York 100
Tokyo 99
Jakarta 85
Hanoi 74
Woodbridge 65
Alexandria 52
Helsinki 52
Houston 52
Lauterbourg 52
Seattle 50
Ferrara 46
Baghdad 45
Cairo 44
Wilmington 40
Buffalo 39
Chicago 39
Milan 39
Shanghai 39
Cambridge 37
London 34
Mexico City 34
Munich 34
Ann Arbor 33
Orem 33
Warsaw 33
Bologna 32
Montreal 32
São Paulo 32
Rome 31
Toronto 31
Atlanta 30
Princeton 28
Frankfurt am Main 24
Hefei 24
Brooklyn 23
Naples 22
Lappeenranta 21
Boston 19
Denver 19
Jacksonville 19
Poplar 19
Falkenstein 18
Izmir 18
Johannesburg 18
Manchester 18
Nanjing 18
San Francisco 18
Da Nang 17
Phoenix 17
Quito 17
Lima 16
Kuala Lumpur 15
Sydney 15
Ankara 14
Chennai 14
Nairobi 14
Najaf 14
San Diego 14
Athens 13
Miami 13
New Delhi 13
Nuremberg 13
Padova 13
Riyadh 13
Amsterdam 12
Haiphong 12
Lahore 12
Mumbai 12
Secaucus 12
Charlotte 11
City of London 11
Cuenca 11
Guayaquil 11
La Paz 11
Stockholm 11
Columbus 10
Delhi 10
Hillah 10
Melbourne 10
Moscow 10
Rio de Janeiro 10
Surabaya 10
Tanta 10
The Dalles 10
Vienna 10
Budapest 9
Cincinnati 9
Dhaka 9
Totale 5.589
Nome #
Systemic lupus erythematosus: one year in review 2023 969
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 444
Novel insights into the management of rheumatoid arthritis: one year in review 2022 293
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 285
Novel insights into the management of rheumatoid arthritis: one year in review 2023 274
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 259
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 244
Biological and synthetic target DMARDs in psoriatic arthritis 201
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 200
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 196
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 195
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 190
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 183
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 182
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 181
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 178
Systemic lupus erythematosus: one year in review 2024 171
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 166
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 159
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 158
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 157
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 156
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 155
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 153
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 150
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 149
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 148
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 148
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 147
One year in review 2018: novelties in the treatment of rheumatoid arthritis 144
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 143
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 141
Neurologic Involvement in Rheumatic Diseases 136
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 136
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 136
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 136
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 133
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 131
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 123
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 122
Systemic lupus erythematosus: one year in review 2025 119
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 119
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 102
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 100
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 97
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 96
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 96
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 95
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 94
One year in review 2021: novelties in the treatment of rheumatoid arthritis 91
One year in review 2019: novelties in the treatment of rheumatoid arthritis 89
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 84
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 81
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 80
One year in review 2020: novelties in the treatment of rheumatoid arthritis 75
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 74
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 66
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review 56
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 55
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in overweight and obese patients: a narrative review 50
Systemic lupus erythematosus: one year in review 2026 44
Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 44
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 41
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study 27
Assessing the sensitivity and the clinical impact of the 2023 ACR/EULAR classification criteria in Obstetric Antiphospholid Syndrome: findings from a multicenter Italian cohort with a long-term follow-up 26
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort 19
Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study 19
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 17
Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. 12
A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus 3
Totale 9.943
Categoria #
all - tutte 42.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 385
Totale 42.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022247 12 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20265.760 431 210 622 498 784 291 618 331 508 618 521 328
2026/2027432 432 0 0 0 0 0 0 0 0 0 0 0
Totale 9.943